These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27266543)

  • 1. HIV-1 Immunogen: an overview of almost 30 years of clinical testing of a candidate therapeutic vaccine.
    Graziani GM; Angel JB
    Expert Opin Biol Ther; 2016 Jul; 16(7):953-66. PubMed ID: 27266543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic vaccine trails in Thailand.
    Churdboonchart V
    J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 immunogen (remune).
    Newsline People AIDS Coalit N Y; 1998 Dec; ():36. PubMed ID: 11367099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remune trial will stop; new trials planned.
    James JS
    AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.
    Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J
    Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-specific immune responses restored by HIV immunogen plus antiretroviral suppression.
    James JS
    AIDS Treat News; 1998 Jul; (No 298):1-5. PubMed ID: 11365597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salk's HIV immunogen: an immune-based therapy in human trials since 1988.
    Crit Path AIDS Proj; 1994-1995 Winter; (No 30):1, 20-3. PubMed ID: 11362152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A boost for the immune system.
    TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine.
    Cafaro A; Tripiciano A; Sgadari C; Bellino S; Picconi O; Longo O; Francavilla V; Buttò S; Titti F; Monini P; Ensoli F; Ensoli B
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S13-29. PubMed ID: 26096836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebuilding immunity with Remune.
    Whitfield L
    Posit Aware; 1998; 9(3):39-40. PubMed ID: 11365486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on HIV vaccines.
    Meldorf M; Corey L
    STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA advisory committees meet January 26 on Salk HIV-1 immunogen.
    AIDS Treat News; 1995 Jan; (No 214):1-2. PubMed ID: 11362184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current strategies and limitations of HIV vaccines.
    Kawalekar OU; Shedlock DJ; Weiner DB
    Curr Opin Investig Drugs; 2010 Feb; 11(2):192-202. PubMed ID: 20112169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remune. Immune Response.
    Lai D; Jones T
    Curr Opin Investig Drugs; 2002 Mar; 3(3):391-8. PubMed ID: 12054085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune interventions in HIV infection.
    Carcelain G; Autran B
    Immunol Rev; 2013 Jul; 254(1):355-71. PubMed ID: 23772631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape review of current HIV 'kick and kill' cure research - some kicking, not enough killing.
    Thorlund K; Horwitz MS; Fife BT; Lester R; Cameron DW
    BMC Infect Dis; 2017 Aug; 17(1):595. PubMed ID: 28851294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccines.
    Surenaud M; Lacabaratz C; Zurawski G; Lévy Y; Lelièvre JD
    Expert Rev Vaccines; 2017 Oct; 16(10):955-972. PubMed ID: 28879788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV immunotherapy comes of age: implications for prevention, treatment and cure.
    Routy JP; Mehraj V; Cao W
    Expert Rev Clin Immunol; 2016; 12(2):91-4. PubMed ID: 26629806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A primer on HIV type 1-specific immune function and REMUNE.
    Moss RB; Giermakowska WK; Savary JR; Theofan G; Daigle AE; Richieri SP; Jensen FC; Carlo DJ
    AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S167-75. PubMed ID: 9672235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of HIV-1-infected Thai patients immunized with Remune monotherapy.
    Sukeepaisarncharoen W; Churdboonchart V; Kulpradist S; Isarangkura Na Ayudthya B; Rugpao S; Chandeying V; Sirawaraporn W; Carlo D; Moss RB
    HIV Clin Trials; 2001; 2(5):391-8. PubMed ID: 11673813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.